Influence of the COVID‐19 Pandemic on the Prevalence of Depression Among US Adults
Canadian Respiratory Journal · 2026-01 · 2026 (1)
DOI: 10.1155/carj/2846550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, online erschienen am 12.04.2026. Verfasst von Jixiang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Beijing University of Chinese Medicine, No. 11 North 3rd Ring East Road Chaoyang, Beijing, 100029, China, bucm.edu.cn. Hauptthemen laut MEDLINE: COVID-19, Depression. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Administration of Traditional Chinese Medicine.
Themen: Depression
Abstract (Originalsprache)
Background
The prevalence of depressive symptoms increased significantly in the early stages of the COVID‐19 pandemic and remained elevated even as lockdown policies were eased. Therefore, a thorough evaluation of the pandemic’s long‐term effects on depressive disorders is critical.
Methods
A repeated cross‐sectional study was conducted using data from the National Health Interview Survey collected before (2017–2018) and during the later stage of the COVID‐19 pandemic (August 2021−August 2023). χ 2 tests were conducted to compare the characteristics between nondepressed and depressed adults. Weighted multivariable logistic regression models were employed to estimate the associations between social and physical factors with depressive symptoms.
Results
The prevalence of depressive symptoms in the later stages of the COVID‐19 pandemic (12.7%) was significantly higher than prepandemic levels (9.1%). Specifically, the incidence rates for mild, moderate, moderately severe, and severe depressive symptoms increased by 1.24‐fold, 1.44‐fold, 1.38‐fold, and 1.71‐fold, respectively, compared to prepandemic levels. Higher risk of developing depressive disorders persisted among those who were widowed/divorced/separated, never married, and with lower education or income. Prepandemic protective factors such as lower systemic inflammatory response index, no smoking or drinking, and no hypertension history became less effective. Males and females aged 20–40 exhibited the highest probability of developing depressive symptoms in the later stage of the pandemic.
Limitations
The cross‐sectional design prevents inference of causality.
Conclusions
The persistence of mental health disparities highlights the need for sustained efforts from the government, mental healthcare organizations, and healthcare providers to support vulnerable groups even beyond the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Beijing University of Chinese Medicine, No. 11 North 3rd Ring East Road Chaoyang, Beijing, 100029, China, bucm.edu.cn.
- Department of Gastroenterology, Beijing Traditional Chinese Medicine Hospital, Capital Medical University, Dongcheng District, Beijing, China, ccmu.edu.cn.
ORCID-Profile: Jixiang Liu, Yichong Wang, Ning Ding, Shengsheng Zhang
Förderung
- National Administration of Traditional Chinese Medicine
Zitieren
APA
Liu, J., Wang, Y., Ding, N., & Zhang, S. (2026). Influence of the COVID‐19 Pandemic on the Prevalence of Depression Among US Adults. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/2846550
Vancouver
Liu J, Wang Y, Ding N, Zhang S. Influence of the COVID‐19 Pandemic on the Prevalence of Depression Among US Adults. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/2846550
BibTeX
@article{Liu2026,
author = {Liu, Jixiang and Wang, Yichong and Ding, Ning and Zhang, Shengsheng},
title = {Influence of the COVID‐19 Pandemic on the Prevalence of Depression Among US Adults},
journal = {Canadian Respiratory Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/carj/2846550}
}
EUVIMED